Figure 1
From: Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
NB-risk subgroups (low and high) inferred from ploidy, ATRX mutations, MYCN amplifications, TERT activation (by genomic rearrangements) and alternative lengthening of telomeres activation
